Medicinal Cannabis Access Data Dashboard

Medicinal Cannabis Access Data Dashboard

To improve transparency and data accessibility, the TGA publishes de-identified data on Special Access Scheme approvals and notifications and Authorised Prescriber approvals specific to 'unapproved' medicinal cannabis.

Please note:

  • The Dashboard is updated monthly, with figures correct at the time of publishing. These may change to reflect updates from subsequent application cancellations, withdrawals and amendments.
  • The Dashboard includes access data since 1992 when TGA received the first known medicinal cannabis SAS application. However, the majority of approvals have occurred since 2016.
  • Sativex (nabiximols) and Epidyolex (cannabidiol) are approved medicinal cannabis products included in the ARTG. Data on the use of these products is not included in the Dashboard.
  • Approval and notification numbers do not equal the actual number of patients receiving these medicines under the SAS. This is because one patient can be associated with repeat applications for a single product as well as with approvals for multiple products. SAS applications contain de-identified patient information, so it is not possible for the TGA to report on individual patient numbers. Under AP, approvals allow a medical practitioner to prescribe a product to multiple patients.
  • SAS and AP approvals or notifications does not mean the patient has accessed or continues to access treatment. Following approval, the actual supply of medicinal cannabis is a matter for the medical practitioner and their patient.

If you have a disability and are unable to use the Dashboard, please contact:  medicinal.cannabis@health.gov.au to access the data in an alternative format.

Comments

Popular posts from this blog

Freedom of information (FOI)